Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodies
Tetsuya Inoue(Tokyo University of Science), Kohji Noguchi(Tokyo University of Science)
Cited by 1
Related Papers
Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in refractory ascites: Post-marketing surveillance results
|PLoS ONE|2017|56
Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodies
|iScience|2024|11
SARS-CoV-2 Spike Protein Mutation at Cysteine-488 Impairs Its Golgi Localization and Intracellular S1/S2 Processing
|International Journal of Molecular Sciences|2022|10
Kaposi's sarcoma–associated herpesvirus replication and transcription activator protein activates <i>CD274/PD‐L1</i> gene promoter
|Cancer Science|2022|7
Functional Effects of AKT3 on Aurora Kinase Inhibitor-induced Aneuploidy
|Journal of Biological Chemistry|2016|5